These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 11476756

  • 1. Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid.
    Chapman AG, Talebi A, Yip PK, Meldrum BS.
    Eur J Pharmacol; 2001 Jul 20; 424(2):107-13. PubMed ID: 11476756
    [Abstract] [Full Text] [Related]

  • 2. Anticonvulsant activity of a metabotropic glutamate receptor 8 preferential agonist, (R,S)-4-phosphonophenylglycine.
    Chapman AG, Nanan K, Yip P, Meldrum BS.
    Eur J Pharmacol; 1999 Oct 21; 383(1):23-7. PubMed ID: 10556677
    [Abstract] [Full Text] [Related]

  • 3. Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893).
    Chapman AG, Nanan K, Williams M, Meldrum BS.
    Neuropharmacology; 2000 Jul 10; 39(9):1567-74. PubMed ID: 10854901
    [Abstract] [Full Text] [Related]

  • 4. Seizures induced by homocysteic acid in immature rats are prevented by group III metabotropic glutamate receptoragonist (R,S)-4-phosphonophenylglycine.
    Folbergrová J, Haugvicová R, Mares P.
    Exp Neurol; 2003 Mar 10; 180(1):46-54. PubMed ID: 12668148
    [Abstract] [Full Text] [Related]

  • 5. The mGlu(2/3) agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti- and proconvulsant in DBA/2 mice.
    Moldrich RX, Talebi A, Beart PM, Chapman AG, Meldrum BS.
    Neurosci Lett; 2001 Feb 16; 299(1-2):125-9. PubMed ID: 11166954
    [Abstract] [Full Text] [Related]

  • 6. Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats.
    Tang E, Yip PK, Chapman AG, Jane DE, Meldrum BS.
    Eur J Pharmacol; 1997 May 30; 327(2-3):109-15. PubMed ID: 9200548
    [Abstract] [Full Text] [Related]

  • 7. Glutamate metabotropic receptors as targets for drug therapy in epilepsy.
    Moldrich RX, Chapman AG, De Sarro G, Meldrum BS.
    Eur J Pharmacol; 2003 Aug 22; 476(1-2):3-16. PubMed ID: 12969743
    [Abstract] [Full Text] [Related]

  • 8. Group II and III metabotropic glutamate receptors modulate paired pulse depression in the rat dentate gyrus in vitro.
    O'Leary DM, Cassidy EM, O'Connor JJ.
    Eur J Pharmacol; 1997 Dec 04; 340(1):35-44. PubMed ID: 9527504
    [Abstract] [Full Text] [Related]

  • 9. Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists.
    Johnson MP, Kelly G, Chamberlain M.
    J Neuroendocrinol; 2001 Aug 04; 13(8):670-7. PubMed ID: 11489083
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795).
    Moldrich RX, Jeffrey M, Talebi A, Beart PM, Chapman AG, Meldrum BS.
    Neuropharmacology; 2001 Jul 04; 41(1):8-18. PubMed ID: 11445181
    [Abstract] [Full Text] [Related]

  • 13. Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice.
    Moldrich RX, Beart PM, Jane DE, Chapman AG, Meldrum BS.
    Neuropharmacology; 2001 Apr 04; 40(5):732-5. PubMed ID: 11311902
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices.
    Bushell TJ, Jane DE, Tse HW, Watkins JC, Garthwaite J, Collingridge GL.
    Br J Pharmacol; 1996 Apr 04; 117(7):1457-62. PubMed ID: 8730739
    [Abstract] [Full Text] [Related]

  • 15. Differential roles of mGlu8 receptors in the regulation of glutamate and gamma-aminobutyric acid release at periaqueductal grey level.
    Marabese I, de Novellis V, Palazzo E, Mariani L, Siniscalco D, Rodella L, Rossi F, Maione S.
    Neuropharmacology; 2005 Apr 04; 49 Suppl 1():157-66. PubMed ID: 16084932
    [Abstract] [Full Text] [Related]

  • 16. Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.
    Domin H, Gołembiowska K, Jantas D, Kamińska K, Zięba B, Smiałowska M.
    Neurotox Res; 2014 Jul 04; 26(1):99-113. PubMed ID: 24402869
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: In vitro and in vivo studies.
    Domin H, Przykaza Ł, Jantas D, Kozniewska E, Boguszewski PM, Śmiałowska M.
    Neuropharmacology; 2016 Mar 04; 102():276-94. PubMed ID: 26647070
    [Abstract] [Full Text] [Related]

  • 18. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord.
    Howson PA, Jane DE.
    Br J Pharmacol; 2003 May 04; 139(1):147-55. PubMed ID: 12746233
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of group I metabotropic glutamate receptor responses in vivo in rats by a new generation of carboxyphenylglycine-like amino acid antagonists.
    Kingston AE, Griffey K, Johnson MP, Chamberlain MJ, Kelly G, Tomlinson R, Wright RA, Johnson BG, Schoepp DD, Harris JR, Clark BP, Baker RS, Tizzano JT.
    Neurosci Lett; 2002 Sep 20; 330(2):127-30. PubMed ID: 12231428
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of seizures induced by homocysteic acid in immature rats by metabotropic glutamate group II and group III receptor agonists.
    Folbergrová J, Haugvicová R, Mares P.
    Brain Res; 2001 Jul 27; 908(2):120-9. PubMed ID: 11454322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.